Tenevid

Safe in patients will mild, moderate, or severe renal impairment or end-stage renal disease without dose adjustment and Patients with mild-to-moderate hepatic impairment.
Novel anti hyper glycemic agents.
Recommended as second- or first-line agents for T2DM2.

Related Products

Glimivid MF
Vogvid
Vogvid MF
Tenevid
Tenevid MF
Metforvid
© Copyright 2022 Elixir Remedies. All Right Reserved.